J Korean Med Assoc.  2015 Feb;58(2):105-109. 10.5124/jkma.2015.58.2.105.

High-risk medication use and patient safety

• Park MS

• KMID: 1958371
• DOI: http://doi.org/10.5124/jkma.2015.58.2.105

Abstract

Medication safety is a significant issue in hospitals everywhere. Although the number of errors caused by high risk medication is less common, the impact on the patient is more critical due to their potentially fatal outcome. Great improvements are needed to reduce errors and increase this aspect of patient safety. Several health quality organizations have reported a list of high-risk medications and useful clinical guidelines, including improving communication, standardizing medication order protocols, providing decision-support tools, and continually monitoring for errors. It is evident that systemic redesign would be more effective in quality improvement; however, given that the medication process is not the same in each institute, root cause analysis based on each error report should be carried out to improve medication safety. Moreover, it is worth noting that leadership should play an important role in the creation of a culture that supports and promotes a strong health and safety performance of an organization.

Keyword

Medication errors; High-risk medication; Patient safety

MeSH Terms

Fatal Outcome
Humans
Leadership
Medication Errors
Patient Safety*
Quality Improvement
Root Cause Analysis

Reference

1. Kohn LT, Corrigan J, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press;1999.

2. Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ. 2000; 320:741–744.

3. Agency for Healthcare Research and Quality. Patient safety and health information technology e-newsletter. Rockville: Agency for Healthcare Research and Quality;2005. cited 2014 Dec 26. Available from:http://archive.ahrq.gov/news/ptsnews/ptsnews15.htm.

4. Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006; 15:369–386.

5. Classen DC, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010; 36:12–21.

6. Institute for Safe Medication Practices. ISMP high alert medication. Horsham: Institute for Safe Medication Practices;2014. cited 2014 Dec 26. Available from:https://www.ismp.org/tools/highalertmedicationLists.asp.

7. Institute for Healthcare Improvement. How-to guide: prevent harm from high-alert medications. Cambridge: Institute for Healthcare Improvement;2012. cited 2014 Dec 25. Available from:http://www.ihi.org/resources/Pages/Tools/HowtoGuidePreventHarmfromHighAlertMedications.aspx.

8. Joint Commission International. Joint Commission International accreditation standards for hospitals. 5th ed. Oak Brook: Joint Commission International;2013.

9. Raju TN, Kecskes S, Thornton JP, Perry M, Feldman S. Medication errors in neonatal and paediatric intensive-care units. Lancet. 1989; 2:374–376.

10. Kaushal R. Computerized physician order entry (CPOE) and clinical decision support systems (CDSSs). In : Shojania K, McDonald K, Wachter R, editors. Making health care safer: a critical analysis of patient safety practices. Rockville: Agency for Healthcare Research and Quality;2011. p. 59–69.

11. Institute for Safe Medication Practices. ISMP's guidelines for standard order sets. Horsham: Institute for Safe Medication Practices;2010. cited 2014 Dec 27. Available from:http://ismp.org/Tools/guidelines/StandardOrderSets.pdf.

12. Joslin EP, Lahey FH. Diabetes and hyperthyroidism. Ann Surg. 1934; 100:629–637.

13. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care. 2006; 15:89–91.

14. Hirsch IB. Sliding scale insulin: time to stop sliding. JAMA. 2009; 301:213–214.

15. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995; 274:35–43.

16. Walsh KE, Kaushal R, Chessare JB. How to avoid paediatric medication errors: a user's guide to the literature. Arch Dis Child. 2005; 90:698–702.

17. Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, Pamer C. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001; 58:1835–1841.

18. Rogers AE, Hwang WT, Scott LD, Aiken LH, Dinges DF. The working hours of hospital staff nurses and patient safety. Health Aff (Millwood). 2004; 23:202–212.

19. Mayo AM, Duncan D. Nurse perceptions of medication errors: what we need to know for patient safety. J Nurs Care Qual. 2004; 19:209–217.

20. Ulanimo VM, O'Leary-Kelley C, Connolly PM. Nurses' perceptions of causes of medication errors and barriers to reporting. J Nurs Care Qual. 2007; 22:28–33.

21. O'Shea E. Factors contributing to medication errors: a literature review. J Clin Nurs. 1999; 8:496–504.

22. Winterstein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm. 2002; 59:1742–1749.

23. Blegen MA, Vaughn TE, Goode CJ. Nurse experience and education: effect on quality of care. J Nurs Adm. 2001; 31:33–39.

24. Tang FI, Sheu SJ, Yu S, Wei IL, Chen CH. Nurses relate the contributing factors involved in medication errors. J Clin Nurs. 2007; 16:447–457.

25. Reason J. Human error: models and management. BMJ. 2000; 320:768–770.

26. Taxis K, Barber N. Causes of intravenous medication errors: an ethnographic study. Qual Saf Health Care. 2003; 12:343–347.

27. Fijn R, Van den Bemt PM, Chow M, De Blaey CJ, De Jong-Van den Berg LT, Brouwers JR. Hospital prescribing errors: epidemiological assessment of predictors. Br J Clin Pharmacol. 2002; 53:326–331.

28. The Joint Commision. Sentinel event data root causes by event type 2004-2Q 2014. Oakbrook Terrace: The Joint Commision;2014. cited 2014 Dec 27. Available from:http://www.jointcommission.org/assets/1/18/Root_Causes_by_Event_Type_2004-2Q_2014.pdf.